Evidence map›Paper›PMID 39448844›Full record

ArticleNature chemical biology2025

Delineating cysteine-reactive compound modulation of cellular proteostasis processes.

Ashley R Julio, Flowreen Shikwana, Cindy Truong, Nikolas R Burton, Emil R Dominguez, Alexandra C Turmon, Jian Cao, Keriann M Backus

Abstract read
In one paragraph

Article in Nature chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Stressing out with electrophiles.Nature chemical biology · 2025
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ashley R Julio *Department of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0002-6258-2849
Flowreen Shikwana *Department of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Cindy TruongDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Nikolas R BurtonDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0003-2887-8846
Emil R DominguezDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Alexandra C TurmonDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Jian CaoDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
Keriann M BackusDepartment of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. kbackus@mednet.ucla.edu.ORCID http://orcid.org/0000-0001-8541-1404

Funding

Chemistry Biology Interface Training ProgramT32GM136614 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Patrick G. Harran · 2020 to 2026
$2.8M
A systems-level approach to decipher the protein interactome.DP2GM146246 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BACKUS, KERIANN MARIE · 2021 to 2024
$2.3M
Arnold and Mabel Beckman Foundation Beckman Young Investigator AwardNIGMS NIH HHS DP2 GM146246NIGMS NIH HHS T32 GM136614United States Department of Defense | Defense Advanced Research Projects Agency (DARPA) D19AP00041U.S. Department of Health & Human Services | National Institutes of Health (NIH) GM146246-02U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) T32GM136614
6 · The paper itself

Abstract

Covalent modulators and covalent degrader molecules have emerged as drug modalities with tremendous therapeutic potential. Toward realizing this potential, mass spectrometry-based chemoproteomic screens have generated proteome-wide maps of potential druggable cysteine residues. However, beyond these direct cysteine-target maps, the full scope of direct and indirect activities of these molecules on cellular processes and how such activities contribute to reported modes of action, such as degrader activity, remains to be fully understood. Using chemoproteomics, we identified a cysteine-reactive small molecule degrader of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nonstructural protein 14 (nsp14), which effects degradation through direct modification of cysteines in both nsp14 and in host protein disulfide isomerases. This degrader activity was further potentiated by generalized electrophile-induced global protein ubiquitylation, proteasome activation and widespread aggregation and depletion of host proteins, including the formation of stress granules. Collectively, we delineate the wide-ranging impacts of cysteine-reactive electrophilic compounds on cellular proteostasis processes.

Indexed as

CysteineProteostasisSARS-CoV-2Small Molecule LibrariesViral Nonstructural ProteinsCOVID-19HumansProteasome Endopeptidase ComplexProtein Disulfide-IsomerasesUbiquitinationCysteineProteasome Endopeptidase ComplexProtein Disulfide-IsomerasesSmall Molecule LibrariesViral Nonstructural Proteins

Identifiers

PMID39448844
PMCPMC12988817

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.